Sambros Pharmaceuticals Private Limited
About Sambros Pharmaceuticals Private Limited
Data last updated:
Sambros Pharmaceuticals Private Limited is a private limited company based in Muzaffarpur, Bihar, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 14 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24100BR2016PTC025725. Its GSTIN is 10AAWCS6414M1ZY (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Syed Ali Murtaza and Arvind Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Dr Sgm Memorial Hospital Bhabha Nagar Road Bhagwanpur Chowk, Muzaffarpur, Bihar, India – 842001.
As per the financials filed for FY 2017, the company reported a revenue of ₹2.98 Lakh. For the same year it recorded a net profit of ₹2,046 (net margin 0.7%) and EBITDA of ₹14,770 (EBITDA margin 5%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sambros Pharmaceuticals Private Limited's registered office is in Muzaffarpur, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDr Sgm Memorial Hospital Bhabha Nagar Road Bhagwanpur Chowk, Muzaffarpur, Bihar, India – 842001
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Sambros Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sambros Pharmaceuticals Private Limited
FY 2024 filings availableSambros Pharmaceuticals Private Limited reported revenue of ₹2.98 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹2.98 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹14,770 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹2,046 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5% | |
| Net Profit Margin | 0.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Sambros Pharmaceuticals Private Limited, buy the company report.
Board of directors and KMP of Sambros Pharmaceuticals Private Limited
Sambros Pharmaceuticals Private Limited currently reports 3 directors and 1 key managerial person. 1 former director has served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Ali Murtaza | Director | 14 Jan 2016 | 10 Years 9 Months | Current |
| Ajit Kumar Shrivastwa Also directs: Sambros Healthcare LLP | Ceo | 14 Jan 2016 | 10 Years 9 Months | Current |
| Arvind Kumar | Director | 14 Jan 2016 | 10 Years 9 Months | Current |
| Firoz Ahmad | Director | 14 Jan 2016 | 10 Years 9 Months | Current |
Auditor
Sambros Pharmaceuticals Private Limited is audited by AGRAWAL NATHANI & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWAL NATHANI & COMPANY | FY 2017 | 019580C |
Shareholding
The shareholding of Sambros Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sambros Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sambros Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sambros Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sambros Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAWCS6414M1ZY | Bihar | Active | 30 Oct 2017 |
To see the full GST registrations and return filing status of Sambros Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sambros Pharmaceuticals Private Limited has 5 board changes on record since 2016: 4 appointments and 1 cessation. The latest: Ajit Kumar Shrivastwa ceased to be Director on 15 May 2017.
Frequently asked questions
Sambros Pharmaceuticals is an active private limited company based in Muzaffarpur, Bihar, India. The company works in retailers, within the trading industry. It was incorporated on 14 January 2016 (10+ years old) and is registered under CIN U24100BR2016PTC025725.
Sambros Pharmaceuticals has 4 current directors and KMP:
- Syed Ali Murtaza - Director
- Arvind Kumar - Director
- Firoz Ahmad - Director
- Ajit Kumar Shrivastwa - Ceo
The latest financial statements of Sambros Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sambros Pharmaceuticals is 10AAWCS6414M1ZY, registered in Bihar.
The CIN (Corporate Identification Number) of Sambros Pharmaceuticals is U24100BR2016PTC025725. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sambros Pharmaceuticals was incorporated on 14 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
Ajit Kumar Shrivastwa ceased to be Director on 15 May 2017. Ajit Kumar Shrivastwa was appointed as CEO on 14 Jan 2016. Arvind Kumar was appointed as Director on 14 Jan 2016. Sambros Pharmaceuticals has 5 board changes on record in total.
The registered office of Sambros Pharmaceuticals is at Dr Sgm Memorial Hospital Bhabha Nagar Road Bhagwanpur Chowk, Muzaffarpur, Bihar, India – 842001.
Sambros Pharmaceuticals operates in the trading industry, in the retailers segment.
The compliance status of Sambros Pharmaceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
